Psilocybin mushrooms, a traditional psychedelic similar to LSD in their role as a serotonin 5-HT2A receptor agonist, are currently under investigation for their potential in psilocybin-assisted therapy. This therapy could potentially aid in treating mental health conditions such as major depression, anxiety, cluster headaches, and migraines, all of which are associated with emotional distress.
Understanding how shrooms can assist in treating these conditions requires an examination of their metabolism within the body. This knowledge allows both researchers and users to comprehend how the active compound triggers therapeutic and psychological effects. This article offers an essential overview of psilocybin’s pharmacology and pharmacokinetics.
[toc]
Key Takeaways:
- Fifty percent of the psychedelic fungi ingested orally is absorbed and distributed throughout the body.
- The compound within the fungi undergoes a process called dephosphorylation, primarily in the liver, via the enzyme alkaline phosphatase.
- Approximately 3.4% of the compound is expelled in its original form within a day, while the majority is excreted as a stable metabolite.
What is Pharmacokinetics?
Pharmacokinetics (PK) is a field of study that examines how substances, such as drugs, are processed by the body once ingested. Though related to pharmacodynamics, which focuses on how a compound interacts with the body, PK specifically investigates four main facets: absorption, distribution, metabolism, and excretion (ADME).
Comprehending these processes allows medical professionals to prescribe the most effective medications with minimal risks. This understanding also allows them to customize treatments based on each patient’s unique physiological makeup and lifestyle.
How does Pharmacokinetics Relate to Psilocybin?
The primary active compounds in certain types of magic mushrooms, psilocybin and psilocin, have garnered significant attention among both users and researchers. Pharmacokinetics provides insights into how the body processes mushrooms that contain psilocybin, furthering our understanding of their potential medicinal or recreational effects.
These compounds, often referred to as “magic,” “psychedelic,” “medicinal,” or “sacred,” are found in specific types of fungi. These fungi are typically consumed, and the types of these mushrooms. Their origin, size, growing and drying conditions, and age can all significantly alter their concentrations.
While these mushrooms naturally occur in the wild, scientists have also created ways to produce them in a lab. Both wild and lab-grown versions have low toxicity, however, they may cause minor side effects such as nausea or vomiting.
Despite these physical side effects, the compounds found in these mushrooms have shown potential therapeutic benefits. This is due to their safe profile and non-addictive nature. These benefits have prompted research into their use in psychotherapy, specifically for treating anxiety and depression.
The 4 Phases of Pharmacokinetics
Psilocybin, the compound found in these mushrooms, is inactive in its native form. It acts as a prodrug, transforming into its active form, psilocin, with the help of enzymes like alkaline phosphatase. This allows psilocin to be absorbed and circulated throughout the body, reaching various tissues. However, after oral administration, psilocybin cannot be detected in the circulatory system, feces, or urine.
Absorption
Absorption is the process by which the compound enters the bloodstream from the point of administration. This affects the speed and effectiveness with which the compound reaches its target, such as the plasma. Oral consumption is the most commonly used method of administration. Inhalation has been tried, but it is not as effective as taking it orally.
The absorption process also involves the release of the compound from the dosage form during oral ingestion. Factors like delays in the throat or esophagus can influence this, potentially slowing down the effects or causing irritation. Once the compound gets to the stomach, the acidic environment may start to break it down before it enters the bloodstream.
Animal studies suggest that only around 50% of orally administered psychedelics are absorbed and distributed throughout the body.
Variables Affecting the Absorption Process
Several factors can affect the absorption process, leading to variations in the onset, intensity, and duration of effects:
- Stomach Contents: Having a full stomach can slow down the process as it delays the onset of effects. An empty stomach allows for quicker absorption.
- Body Fat: Substances may accumulate in fat tissues, potentially prolonging their effects.
- Age: As people age, their metabolic rates and body composition can change.
- Zero-Order Kinetics: The substance is expelled at a steady rate, regardless of its concentration.
- First-Order Kinetics: The elimination rate is directly proportional to the concentration of the drug.
This process is heavily influenced by factors such as the substance’s size, polarity, and protein-binding capacity, as well as individual physiological factors like hydration status and body composition.
The aim is to achieve an effective concentration in the target area. To be effective, the substance must get to the intended location, as defined by the volume of distribution, and remain unattached to proteins, allowing it to actively engage with its receptor.
What Affects the Distribution Process?
A few factors can influence the distribution process:
Generally, the effects begin to manifest between 20 to 40 minutes after ingestion, peaking around 80 to 100 minutes, and lasting for about 4 to 6 hours.
How is Distribution to the Brain Achieved?
Early experimental studies on two species show that its binding affinity sequence is 5HT2A > 5HT1A > 5HT2B [23]. It also interacts with dopamine D1, 5HT1E, 5HT5A, 5HT7, 5HT6, D3, 5HT2C, and 5HT1B receptors.
Psilocin acts as a partial agonist at the 5HT2A receptor, with a efficacy of approximately 40%. The psychedelic effects can be traced back to its partial agonist activity at 5HT1A autoreceptors.
The mood-enhancing and psychotomimetic experiences might be linked to the observed rise in dopamine levels, which are associated with feelings of depersonalization and euphoria. Hallucinogens work by modifying neurochemistry and receptor activity. They enhance 5HT2A agonist activity by increasing BDNF synthesis in the hippocampus, which promotes neurogenesis and reduces conditioned fear-related behaviors.
Elimination
Elimination refers to how the The body disposes of a certain compound mainly through the kidneys, but it can also be expelled via the lungs, skin or gastrointestinal tract. In the kidney, this compound – a naturally occurring psychedelic drug – is filtered in the glomerulus or secreted in the tubules. The process is further complicated by some degree of reabsorption.
The primary compound has a half-life of roughly 160 minutes, whereas psilocin’s half-life is approximately 50 minutes. Animal studies indicate that the majority of this compound is expelled through urine, making up about 65% within 8 hours after consumption. Residual amounts of the substance can also be detected in bile and feces.
Within the human body, about 3.4% of the drug is expelled in its original form within 24 hours. However, most of it is excreted as psilocin-O-glucuronide, a metabolite with enhanced stability. This metabolite can be detected in urine samples for a prolonged duration due to its stability.
Substance excretion primarily occurs through two methods:
Most psychedelic drugs follow the first-order kinetics model, reaching steady-state concentrations after four to five half-lives. Complete removal also typically occurs after approximately four to five half-lives.
Discover Our Variety of Hallucinogenic Mushrooms
Different types of fungi have varying metabolic processes. Purchasing from reliable online retailers such as Micro Zoomiez Canada can help you avoid unintentionally ingesting poisonous mushrooms. Certain kinds, like Agaric mushrooms, can result in potent and undesirable effects. Thus, it’s important to acquire magic mushrooms from trustworthy sources, rather than taking risks with street vendors or foraging in the wild.
| Feature | Enigma | Full Moon Party | Gold Member | |
| Strain Type | Psilocybe Cubensis OMNI | Psilocybe cubensis (Thai Koh Samui) | Psilocybe cubensis | |
| Potency | Extremely high; 3.8% tryptamine content | Moderate to high potency | High potency | |
| Visual Characteristics | Resembles a blob or | Resembles a cauliflower or brain-like structure | Standard appearance for a cubensis; moderate in size | Characteristic white stems; caps are a golden caramel color; evident blue bruising |
| Effects | Recognized as the most powerful; induces profound effects | Produces a potent mental high; onset is delayed but visuals are prominent | Induces powerful visuals and euphoria |
Online Education on Psilocybin Mushroom Usage
For healthcare professionals, researchers, and users, understanding the pharmacokinetics of shrooms is crucial. This knowledge helps you to make well-informed decisions regarding dosage and administration timing, thereby reducing potential risks.
Discover the perfect psychedelic experience at Micro Zoomiez Canada. Whether you desire a restful journey or a deeper exploration, our wide array of products are designed to meet your specific needs. We provide premium, safe, and quality-assured shrooms, eliminating worries about unverified sources or toxic mushrooms.
Experience the best magic mushrooms Canada has to offer and take your psychedelic exploration to new heights.
Frequently Asked Questions
Do shrooms interact with other medications?
Our products might potentially interact with particular medications, particularly those affecting serotonin levels, such as SSRIs (Selective Serotonin Reuptake Inhibitors). SSRIs and SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors) tend to reduce the effects, unlike non-serotonergic antidepressants. This reduced effect can last up to three months after discontinuing the antidepressant.
Do all psychedelics operate in the same way as psilocybin?
No, each psychedelic substance has a unique structure that requires different metabolic processes to activate, and they bind to various receptors in the body. The administration method also affects each psychedelic’s absorption. While the basic principles of absorption, metabolism, and distribution remain the same, the specific pathways and effects vary for each substance.
Can the form of the shroom affect the pharmacokinetics?
Yes, the form (whether it’s fresh, powdered, or dried mushrooms) can influence the rate of absorption. For example, powdered forms may be absorbed faster than whole dried ones due to quicker dissolution.
Related Reads:
